Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catalina Raymond

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
AJNR. American Journal of Neuroradiology|September 6, 2024
"Synthetic" DSC Perfusion MRI with Adjustable Acquisition Parameters in Brain Tumors Using Dynamic Spin-and-Gradient-Echo Echoplanar ImagingFrancesco Sanvito, Jingwen Yao, Nicholas S Cho, et al.
Scientific Reports|July 19, 2020
Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective studyJingwen Yao, Akifumi Hagiwara, Catalina Raymond, et al.
Clinical Nuclear Medicine|October 8, 2020
Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI StudyHiroyuki Tatekawa, Jingwen Yao, Talia C Oughourlian, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 11, 2021
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PETHiroyuki Tatekawa, Akifumi Hagiwara, Hiroyuki Uetani, et al.
Annals of Nuclear Medicine|June 14, 2021
Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burdenHiroyuki Tatekawa, Hiroyuki Uetani, Akifumi Hagiwara, et al.
Schizophrenia Research|April 19, 2021
Cortical morphometric correlational networks associated with cognitive deficits in first episode schizophreniaChencai Wang, Talia Oughourlian, Todd A Tishler, et al.
Tomography (Ann Arbor, Mich.)|June 23, 2022
Characterization of Cognitive Function in Survivors of Diffuse Gliomas Using Morphometric Correlation NetworksChencai Wang, Nicholas S Cho, Kathleen Van Dyk, et al.
Magnetic Resonance in Medicine|April 8, 2018
Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI)Robert J Harris, Jingwen Yao, Ararat Chakhoyan, et al.
Journal of Neuro-Oncology|January 26, 2020
Rate of change in maximum <sup>18</sup>F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomasTalia C Oughourlian, Jingwen Yao, Jacob Schlossman, et al.
Neuro-Oncology Advances|August 29, 2022
Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomasNicholas S Cho, Akifumi Hagiwara, Blaine S C Eldred, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
AJNR. American Journal of Neuroradiology|September 6, 2024
"Synthetic" DSC Perfusion MRI with Adjustable Acquisition Parameters in Brain Tumors Using Dynamic Spin-and-Gradient-Echo Echoplanar ImagingFrancesco Sanvito, Jingwen Yao, Nicholas S Cho, et al.
Scientific Reports|July 19, 2020
Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective studyJingwen Yao, Akifumi Hagiwara, Catalina Raymond, et al.
Clinical Nuclear Medicine|October 8, 2020
Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI StudyHiroyuki Tatekawa, Jingwen Yao, Talia C Oughourlian, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 11, 2021
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PETHiroyuki Tatekawa, Akifumi Hagiwara, Hiroyuki Uetani, et al.
Annals of Nuclear Medicine|June 14, 2021
Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burdenHiroyuki Tatekawa, Hiroyuki Uetani, Akifumi Hagiwara, et al.
Schizophrenia Research|April 19, 2021
Cortical morphometric correlational networks associated with cognitive deficits in first episode schizophreniaChencai Wang, Talia Oughourlian, Todd A Tishler, et al.
Tomography (Ann Arbor, Mich.)|June 23, 2022
Characterization of Cognitive Function in Survivors of Diffuse Gliomas Using Morphometric Correlation NetworksChencai Wang, Nicholas S Cho, Kathleen Van Dyk, et al.
Magnetic Resonance in Medicine|April 8, 2018
Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI)Robert J Harris, Jingwen Yao, Ararat Chakhoyan, et al.
Journal of Neuro-Oncology|January 26, 2020
Rate of change in maximum <sup>18</sup>F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomasTalia C Oughourlian, Jingwen Yao, Jacob Schlossman, et al.
Neuro-Oncology Advances|August 29, 2022
Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomasNicholas S Cho, Akifumi Hagiwara, Blaine S C Eldred, et al.
Pageof 7